| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 18 | 2024 | 538 | 4.000 |
Why?
|
| Leukemia, Myeloid, Acute | 10 | 2024 | 511 | 3.630 |
Why?
|
| Neoplastic Stem Cells | 4 | 2024 | 295 | 1.890 |
Why?
|
| Cell Cycle Proteins | 10 | 2021 | 657 | 1.790 |
Why?
|
| AMP-Activated Protein Kinases | 5 | 2020 | 166 | 1.400 |
Why?
|
| Adult Stem Cells | 2 | 2021 | 54 | 1.320 |
Why?
|
| Leukemia | 6 | 2021 | 357 | 1.200 |
Why?
|
| Transcription Factors | 5 | 2021 | 2580 | 1.190 |
Why?
|
| Hematopoiesis | 5 | 2022 | 219 | 1.160 |
Why?
|
| Erythroid Cells | 2 | 2024 | 27 | 0.980 |
Why?
|
| Homeostasis | 4 | 2021 | 681 | 0.930 |
Why?
|
| Dioxygenases | 1 | 2024 | 46 | 0.880 |
Why?
|
| Estrogens | 2 | 2018 | 505 | 0.870 |
Why?
|
| Cell Differentiation | 5 | 2024 | 1933 | 0.860 |
Why?
|
| Polycomb Repressive Complex 1 | 4 | 2022 | 29 | 0.860 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2022 | 558 | 0.810 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2021 | 13 | 0.770 |
Why?
|
| Histone Chaperones | 1 | 2021 | 11 | 0.770 |
Why?
|
| Saccharomyces cerevisiae Proteins | 6 | 2005 | 274 | 0.740 |
Why?
|
| CRISPR-Cas Systems | 3 | 2018 | 249 | 0.740 |
Why?
|
| DNA-Binding Proteins | 7 | 2024 | 2032 | 0.710 |
Why?
|
| Acetyl Coenzyme A | 1 | 2019 | 14 | 0.690 |
Why?
|
| Anemia | 1 | 2024 | 337 | 0.680 |
Why?
|
| Megakaryocyte-Erythroid Progenitor Cells | 1 | 2019 | 3 | 0.670 |
Why?
|
| Gene Editing | 3 | 2018 | 186 | 0.670 |
Why?
|
| Saccharomyces cerevisiae | 6 | 2005 | 422 | 0.650 |
Why?
|
| Azacitidine | 1 | 2019 | 55 | 0.640 |
Why?
|
| Mice | 22 | 2022 | 17624 | 0.630 |
Why?
|
| Animals | 30 | 2024 | 33870 | 0.630 |
Why?
|
| Adipocytes | 1 | 2019 | 158 | 0.610 |
Why?
|
| DNA Damage | 7 | 2019 | 517 | 0.610 |
Why?
|
| Polycomb-Group Proteins | 1 | 2018 | 18 | 0.610 |
Why?
|
| Clone Cells | 1 | 2018 | 167 | 0.600 |
Why?
|
| Unfolded Protein Response | 1 | 2018 | 62 | 0.590 |
Why?
|
| Cell Cycle | 5 | 2012 | 619 | 0.590 |
Why?
|
| Endoribonucleases | 1 | 2018 | 83 | 0.570 |
Why?
|
| Carcinogenesis | 3 | 2022 | 335 | 0.560 |
Why?
|
| Estrogen Receptor alpha | 2 | 2018 | 449 | 0.550 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2019 | 629 | 0.540 |
Why?
|
| Stem Cells | 4 | 2019 | 710 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 10 | 2021 | 4385 | 0.540 |
Why?
|
| Fungal Proteins | 4 | 2004 | 134 | 0.510 |
Why?
|
| Bone Marrow | 1 | 2015 | 315 | 0.450 |
Why?
|
| Spleen | 3 | 2024 | 287 | 0.440 |
Why?
|
| Histones | 3 | 2021 | 528 | 0.400 |
Why?
|
| Energy Metabolism | 3 | 2020 | 742 | 0.400 |
Why?
|
| Protein Kinases | 1 | 2014 | 330 | 0.400 |
Why?
|
| Guided Tissue Regeneration | 1 | 2011 | 3 | 0.380 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2020 | 551 | 0.350 |
Why?
|
| Oxidative Stress | 1 | 2015 | 794 | 0.350 |
Why?
|
| Clonal Evolution | 2 | 2020 | 38 | 0.350 |
Why?
|
| Stem Cell Niche | 2 | 2020 | 54 | 0.340 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2019 | 64 | 0.330 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2022 | 97 | 0.320 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 2438 | 0.310 |
Why?
|
| Mutation | 8 | 2024 | 5773 | 0.300 |
Why?
|
| Signal Transduction | 10 | 2020 | 4518 | 0.300 |
Why?
|
| Phosphoproteins | 3 | 2012 | 399 | 0.290 |
Why?
|
| Phleomycins | 2 | 2004 | 6 | 0.280 |
Why?
|
| DNA, Fungal | 2 | 2004 | 75 | 0.280 |
Why?
|
| Checkpoint Kinase 2 | 5 | 2024 | 33 | 0.240 |
Why?
|
| Exodeoxyribonucleases | 1 | 2004 | 49 | 0.240 |
Why?
|
| Humans | 24 | 2024 | 121793 | 0.240 |
Why?
|
| Endodeoxyribonucleases | 1 | 2004 | 47 | 0.240 |
Why?
|
| Cell Self Renewal | 2 | 2021 | 41 | 0.240 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2012 | 428 | 0.240 |
Why?
|
| Blood Pressure Determination | 1 | 2024 | 105 | 0.230 |
Why?
|
| Mice, Knockout | 4 | 2021 | 3777 | 0.220 |
Why?
|
| Iron | 2 | 2024 | 263 | 0.220 |
Why?
|
| Arterial Pressure | 1 | 2024 | 104 | 0.220 |
Why?
|
| Phosphorylation | 7 | 2020 | 1616 | 0.210 |
Why?
|
| Selenium | 1 | 2022 | 23 | 0.200 |
Why?
|
| Proteostasis | 1 | 2022 | 34 | 0.200 |
Why?
|
| Gene Ontology | 1 | 2021 | 48 | 0.190 |
Why?
|
| Gene Deletion | 4 | 2016 | 798 | 0.190 |
Why?
|
| NAD | 1 | 2021 | 50 | 0.190 |
Why?
|
| Cell Division | 2 | 2014 | 793 | 0.180 |
Why?
|
| Receptors, Thrombopoietin | 1 | 2020 | 30 | 0.180 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2020 | 22 | 0.180 |
Why?
|
| Multiprotein Complexes | 2 | 2012 | 207 | 0.180 |
Why?
|
| Ribonucleoproteins | 2 | 2018 | 63 | 0.180 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 4306 | 0.170 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2020 | 19 | 0.170 |
Why?
|
| Models, Biological | 2 | 2021 | 1437 | 0.170 |
Why?
|
| Lipid Peroxidation | 1 | 2020 | 83 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2024 | 714 | 0.170 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2012 | 269 | 0.170 |
Why?
|
| Cell Proliferation | 4 | 2016 | 2321 | 0.170 |
Why?
|
| PAX3 Transcription Factor | 1 | 2019 | 27 | 0.170 |
Why?
|
| Animals, Newborn | 2 | 2021 | 1007 | 0.170 |
Why?
|
| Endoplasmic Reticulum | 1 | 2020 | 213 | 0.170 |
Why?
|
| Acetylation | 1 | 2019 | 166 | 0.170 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 286 | 0.160 |
Why?
|
| Reperfusion Injury | 1 | 2020 | 102 | 0.160 |
Why?
|
| Blood Platelets | 1 | 2022 | 327 | 0.160 |
Why?
|
| Hematologic Diseases | 1 | 2019 | 73 | 0.160 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 263 | 0.160 |
Why?
|
| Methylation | 1 | 2019 | 226 | 0.160 |
Why?
|
| Bridged Bicyclo Compounds, Heterocyclic | 1 | 2019 | 39 | 0.160 |
Why?
|
| Adipogenesis | 1 | 2019 | 75 | 0.160 |
Why?
|
| Preleukemia | 1 | 2018 | 1 | 0.160 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2018 | 52 | 0.150 |
Why?
|
| Cellular Senescence | 1 | 2019 | 158 | 0.150 |
Why?
|
| Environmental Exposure | 1 | 2019 | 198 | 0.150 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2020 | 347 | 0.150 |
Why?
|
| INDEL Mutation | 1 | 2018 | 88 | 0.150 |
Why?
|
| Genes, Neoplasm | 1 | 2018 | 79 | 0.150 |
Why?
|
| RNA Interference | 1 | 2019 | 497 | 0.140 |
Why?
|
| RNA, Small Interfering | 1 | 2019 | 664 | 0.140 |
Why?
|
| Translocation, Genetic | 1 | 2019 | 352 | 0.140 |
Why?
|
| Sulfonamides | 1 | 2019 | 258 | 0.140 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 879 | 0.140 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 352 | 0.140 |
Why?
|
| Cellular Microenvironment | 1 | 2016 | 9 | 0.130 |
Why?
|
| Cell Line, Tumor | 2 | 2020 | 3297 | 0.130 |
Why?
|
| Protein Binding | 1 | 2019 | 1736 | 0.130 |
Why?
|
| Replication Protein A | 2 | 2005 | 11 | 0.120 |
Why?
|
| Bone Marrow Transplantation | 1 | 2018 | 579 | 0.120 |
Why?
|
| Trans-Activators | 1 | 2019 | 805 | 0.120 |
Why?
|
| Cell Survival | 2 | 2010 | 817 | 0.120 |
Why?
|
| Age Factors | 1 | 2021 | 2757 | 0.120 |
Why?
|
| Apoptosis | 1 | 2021 | 1791 | 0.120 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 1675 | 0.120 |
Why?
|
| Prosencephalon | 1 | 2014 | 40 | 0.120 |
Why?
|
| Female | 8 | 2024 | 64573 | 0.110 |
Why?
|
| Spheroids, Cellular | 1 | 2014 | 59 | 0.110 |
Why?
|
| Male | 7 | 2024 | 59243 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2018 | 3075 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2022 | 2031 | 0.110 |
Why?
|
| Erythropoiesis | 1 | 2014 | 40 | 0.110 |
Why?
|
| Cell Count | 1 | 2014 | 253 | 0.110 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2013 | 65 | 0.110 |
Why?
|
| Enzyme Activation | 2 | 2012 | 620 | 0.110 |
Why?
|
| Neural Stem Cells | 1 | 2014 | 126 | 0.110 |
Why?
|
| Kidney | 1 | 2020 | 1343 | 0.110 |
Why?
|
| Protein Phosphatase 2C | 2 | 2024 | 55 | 0.100 |
Why?
|
| Sex Characteristics | 1 | 2014 | 306 | 0.100 |
Why?
|
| Cytosol | 1 | 2012 | 160 | 0.100 |
Why?
|
| Disease Progression | 1 | 2018 | 1984 | 0.100 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2019 | 1242 | 0.100 |
Why?
|
| Neoplasms | 2 | 2024 | 2697 | 0.090 |
Why?
|
| DNA Replication | 2 | 2004 | 345 | 0.090 |
Why?
|
| Centrosome | 1 | 2010 | 34 | 0.090 |
Why?
|
| Ovary | 1 | 2014 | 390 | 0.090 |
Why?
|
| Pancytopenia | 1 | 2010 | 40 | 0.090 |
Why?
|
| Spindle Apparatus | 1 | 2010 | 64 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2010 | 155 | 0.090 |
Why?
|
| Aging | 2 | 2014 | 1164 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2010 | 156 | 0.090 |
Why?
|
| Cell Death | 1 | 2010 | 242 | 0.090 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2010 | 163 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2010 | 204 | 0.080 |
Why?
|
| Sirolimus | 1 | 2010 | 220 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 1 | 2015 | 688 | 0.080 |
Why?
|
| Nerve Net | 1 | 2011 | 235 | 0.080 |
Why?
|
| Regeneration | 1 | 2010 | 202 | 0.080 |
Why?
|
| Aged | 3 | 2024 | 18732 | 0.080 |
Why?
|
| Integrases | 2 | 2021 | 162 | 0.070 |
Why?
|
| Mitochondria | 1 | 2010 | 679 | 0.060 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2005 | 66 | 0.060 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2024 | 715 | 0.060 |
Why?
|
| Proteins | 1 | 2010 | 1039 | 0.060 |
Why?
|
| Genes, Fungal | 1 | 2004 | 63 | 0.060 |
Why?
|
| Prone Position | 1 | 2024 | 32 | 0.060 |
Why?
|
| Genes, cdc | 1 | 2004 | 25 | 0.060 |
Why?
|
| Patient Positioning | 1 | 2024 | 54 | 0.060 |
Why?
|
| Monitoring, Intraoperative | 1 | 2024 | 130 | 0.060 |
Why?
|
| Methyl Methanesulfonate | 1 | 2003 | 2 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2003 | 13 | 0.050 |
Why?
|
| G2 Phase | 1 | 2003 | 45 | 0.050 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 1 | 2003 | 90 | 0.050 |
Why?
|
| S Phase | 1 | 2003 | 73 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2010 | 1881 | 0.050 |
Why?
|
| Protein Aggregates | 1 | 2022 | 27 | 0.050 |
Why?
|
| RNA, Ribosomal | 1 | 2022 | 58 | 0.050 |
Why?
|
| Mitosis | 1 | 2003 | 239 | 0.050 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 524 | 0.050 |
Why?
|
| Receptor, TIE-2 | 1 | 2021 | 13 | 0.050 |
Why?
|
| Oncogenes | 1 | 2022 | 171 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2003 | 528 | 0.050 |
Why?
|
| Pregnancy | 1 | 2014 | 7045 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2013 | 342 | 0.050 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2021 | 93 | 0.040 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2003 | 465 | 0.040 |
Why?
|
| Staining and Labeling | 1 | 2021 | 186 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2022 | 297 | 0.040 |
Why?
|
| Cyclohexylamines | 1 | 2020 | 5 | 0.040 |
Why?
|
| Neoplasm Proteins | 1 | 2024 | 669 | 0.040 |
Why?
|
| HEK293 Cells | 2 | 2013 | 742 | 0.040 |
Why?
|
| Heterografts | 1 | 2020 | 183 | 0.040 |
Why?
|
| A549 Cells | 1 | 2020 | 45 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 492 | 0.040 |
Why?
|
| Phenylenediamines | 1 | 2020 | 25 | 0.040 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2020 | 62 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2020 | 102 | 0.040 |
Why?
|
| MCF-7 Cells | 1 | 2020 | 222 | 0.040 |
Why?
|
| Kinetics | 1 | 2021 | 1316 | 0.040 |
Why?
|
| Blood Pressure | 1 | 2024 | 1300 | 0.040 |
Why?
|
| Piperazines | 1 | 2020 | 226 | 0.040 |
Why?
|
| DNA Repair | 2 | 2016 | 580 | 0.040 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 262 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 265 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 453 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2020 | 740 | 0.040 |
Why?
|
| Gene Expression Regulation | 2 | 2020 | 2539 | 0.040 |
Why?
|
| Pyrazoles | 1 | 2020 | 301 | 0.040 |
Why?
|
| Genetic Association Studies | 1 | 2020 | 744 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2020 | 374 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 91 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2016 | 128 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2020 | 882 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2020 | 864 | 0.030 |
Why?
|
| Glucose | 1 | 2020 | 875 | 0.030 |
Why?
|
| Antimitotic Agents | 1 | 2014 | 1 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2020 | 1759 | 0.030 |
Why?
|
| Mice, Mutant Strains | 1 | 2015 | 388 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2015 | 213 | 0.030 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2015 | 156 | 0.030 |
Why?
|
| Pancreas | 1 | 2015 | 214 | 0.030 |
Why?
|
| Dacarbazine | 1 | 2014 | 84 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2014 | 103 | 0.030 |
Why?
|
| Cell Separation | 1 | 2014 | 236 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 25516 | 0.030 |
Why?
|
| Rapamycin-Insensitive Companion of mTOR Protein | 1 | 2012 | 5 | 0.030 |
Why?
|
| Genomics | 1 | 2020 | 1467 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 2 | 1 | 2012 | 28 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2013 | 164 | 0.030 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2012 | 29 | 0.030 |
Why?
|
| Blood Cells | 1 | 2012 | 50 | 0.030 |
Why?
|
| Neuroglia | 1 | 2014 | 192 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2012 | 92 | 0.030 |
Why?
|
| Hydrophobic and Hydrophilic Interactions | 1 | 2012 | 56 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 196 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2015 | 480 | 0.020 |
Why?
|
| Biomarkers | 1 | 2021 | 2926 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2020 | 4623 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2012 | 750 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2010 | 701 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 808 | 0.020 |
Why?
|
| RNA-Binding Proteins | 1 | 2012 | 569 | 0.020 |
Why?
|
| Cell Line | 1 | 2013 | 2787 | 0.020 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1022 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2024 | 15794 | 0.020 |
Why?
|
| Phenotype | 1 | 2014 | 4200 | 0.010 |
Why?
|
| Adult | 1 | 2024 | 28549 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 2004 | 66 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2012 | 1189 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 198 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 446 | 0.010 |
Why?
|
| Time Factors | 1 | 2012 | 6168 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2002 | 401 | 0.010 |
Why?
|
| Replication Protein C | 1 | 2001 | 6 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 668 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2002 | 835 | 0.010 |
Why?
|
| Base Sequence | 1 | 2002 | 3117 | 0.010 |
Why?
|